This sugar-like substance 2 – DDG (2-deoxy-D-glucose) is in a modified form for the diagnosis and visualization of cancer cells called the PET – CT used in conventional medicine for the diagnosis of cancer and for the visualization of tumors, as this sugar accumulates in the cancer cells and “lights up” because cancer cells feed on sugar.
However, 2 – DDG is a sugar that cancer cells cannot process or metabolize so they by the inclusion of 2 – DGG come into a state of hunger and are weakened. In this state of weakness the cancer cells are vulnerable and can die in combination with other therapies.
The substance 2 – DDG (2-deoxy-D-glucose) is an agent that is not yet approved as a drug, and there are no official studies so far on the use of 2 – DDG in humans. In studies on tumor cells, that by administration of 2-DDG an increase in the natural, ie healthy, cellular respiration and inhibition of tumor-specific fermentation metabolism of cancer cells it was demonstrated .
Another mechanism of action lies in the activation of natural cell death, the so-called “apoptosis”, which then leads to the death of cancer cells. In experiments on neuroblastoma cells as part of a doctoral thesis, a tumor cell-destroying effect on these cancer cells was detected.
Ultimately, the effect of the 2-DDG is that this active substance displaces the normal body glucose entering the tumor cell and thus the glucose diet of the tumor cell is reduced, and in this way the cancer cell will “starve”.